Clinical Advances in Major Depressive Disorder: Strategies to Optimize Patient Care and Outcomes

Sunday, June 4, 2023

10:45 AM – 11:45 AM PT

Location: Octavius 11

In this Master Class session, expert faculty will discuss the limitations of traditional antidepressants in the management of MDD, including inadequate response and treatment-emergent adverse effects. The faculty will also compare and contrast the unique mechanisms of action and clinical characteristics of alternative pharmacotherapies, drawing on both clinical trial data and real-world evidence. By participating in this session, attendees will gain practical skills in providing guideline-based, patient-centered, collaborative care for patients with MDD that considers evidence-based treatment and antidepressant switching strategies. By the end of the session, participants will be better equipped to provide effective care for patients with MDD and to navigate the challenges of antidepressant therapy.

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc and Lundbeck.

Speaker(s)

GM

Gregory Mattingly, MD

Associate Clinical Professor
Washington University
Washington University School of Medicine
St Louis, Missouri
Brooke Kempf, MSN, PMHNP-BC

Hospitalist, Hamilton Center CMHC, Terre Haute, IN; Adjunct Faculty, Indiana University of Indianapolis, Indianapolis, IN
Hamilton Center CMHC
Indiana University of Indianapolis
Brazil, Indiana

Moderator(s)

Rakesh Jain, MD

Clinical Professor
Texas Tech - Permian Basin
Texas Tech University School of Medicine - Permian Basin, Midland, Texas
AUSTIN, Texas